fda warning unapproved peptides bpc-157 tb-500 Four-of-seven get the green light from panel The FDA just announced that

There is a striking and concerning lack of human evidence

The advantage of subcutaneous injection is that it is easier to learn at home and less painful

Contact us with facility credentials, target compound, and projected volume

The original 2015 Cell Metabolism study demonstrated that intraperitoneal MOTS-c injections (5 mg/kg) in mice fed a high-fat diet prevented obesity and insulin resistance, with effects on fat mass, fasting glucose, and insulin sensitivity that rivaled pharmaceutical intervention [1]

Cost: shots vs pills In-clinic injections add visit fees

Sources: Novinscak T, Brcic L, Staresinic M, et al